Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure | Heart
Direct cardiac effects of SGLT2 inhibitors | Cardiovascular Diabetology | Full Text
Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care | Diabetes Technology & Therapeutics
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control | Nature Reviews Cardiology
SGLT2 Inhibitors – Diabetologia
Sodium-Glucose Cotransporter 2 Inhibitors: An Overview
Scheme representing the proposed effects of SGLT2 inhibitor on NLRP3... | Download Scientific Diagram
The evolving role of SGLT2 inhibitors - DiabetesontheNet
SGLT2 inhibition effect on salt-induced hypertension, RAAS, and Na+ transport in Dahl SS rats | American Journal of Physiology-Renal Physiology
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure | Heart
Frontiers | Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
Swertisin, a novel SGLT2 inhibitor, with improved glucose homeostasis for effective diabetes therapy - ScienceDirect
SGLT2 Inhibitors for Type 2 Diabetes - How to Talk To Your Doctor About Them | Everyday Health
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications - The Lancet
SGLT2 Inhibitors: What's the story?
SGLT2 Inhibitor-induced Euglycemic Diabetic Ketoacidosis - Renal Fellow Network
Side Effects of SGLT2 Inhibitors - Renal Fellow Network
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations - Kidney International Reports
SGLT2 inhibitor and loop diuretic induce different vasopressin and fluid homeostatic responses in nondiabetic rats | American Journal of Physiology-Renal Physiology
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently | SpringerLink
IJMS | Free Full-Text | Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
